---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-096290"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2022-04-05T23:59:59+00:00"
generated_at: "2026-06-26T09:19:53.669815+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Fluidigm closes $225M convertible preferred financing, renames to Standard BioTools, appoints new CEO and board

## Summary
- Closed $225M private placement of Series B convertible preferred to Casdin and Viking (112,500 shares each at $1,000/share).
- Name changed from Fluidigm to Standard BioTools; authorized common shares doubled to 400M.
- Appointed Michael Egholm as CEO/President and Hanjoon Alex Kim as COO; former CEO Linthwaite resigned.
- Board expanded to 8; new directors: Eli Casdin, Martin Madaus, Frank Witney, and Michael Egholm.
- Adopted 2022 Inducement Plan reserving 9.5M shares; granted Egholm options for 4.5M shares and Kim 1.6M shares at $3.99.

## SEC filing metadata
- accession: 0001193125-22-096290
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2022-04-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 1.02, 3.02, 5.03, 3.03, 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/0001193125-22-096290-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/d314141d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-096290
- JSON: https://secwatch.observer/filing/0001193125-22-096290.json
- Plain text: https://secwatch.observer/filing/0001193125-22-096290.txt

## Key facts
- Executive change
  Michael Egholm was appointed as Director at STANDARD BIOTOOLS INC..
  - Action: appointed
  - Role: Director
  source text: the Board also appointed Michael Egholm as a Class I director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/0001193125-22-096290-index.htm
- Executive change
  Martin Madaus was appointed as Director at STANDARD BIOTOOLS INC..
  - Action: appointed
  - Role: Director
  source text: Viking has designated Martin Madaus as the Series B-2 Director and, accordingly, effective as of the Closing Date, the Board has appointed Dr. Madaus
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/0001193125-22-096290-index.htm
- Executive change
  Stephen Christopher Linthwaite resigned as Director at STANDARD BIOTOOLS INC..
  - Action: resigned
  - Role: Director
  source text: Stephen Christopher Linthwaite, Ana K. Stankovic and Nicolas M. Barthelemy each resigned from the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/0001193125-22-096290-index.htm
- Executive change
  Eli Casdin was appointed as Director at STANDARD BIOTOOLS INC..
  - Action: appointed
  - Role: Director
  source text: Casdin has designated Eli Casdin as the Series B-1 Director and, accordingly, effective as of the Closing Date, the Board has appointed Mr. Casdin to serve as the Series B-1 Director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/0001193125-22-096290-index.htm
- Executive change
  Frank Witney was appointed as Director at STANDARD BIOTOOLS INC..
  - Action: appointed
  - Role: Director
  source text: the Board also appointed Dr. Frank Witney to the Board to serve as a Class III director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/0001193125-22-096290-index.htm
- Executive change
  Ana K. Stankovic resigned as Director at STANDARD BIOTOOLS INC..
  - Action: resigned
  - Role: Director
  source text: Stephen Christopher Linthwaite, Ana K. Stankovic and Nicolas M. Barthelemy each resigned from the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/0001193125-22-096290-index.htm
- Executive change
  Nicolas M. Barthelemy resigned as Director at STANDARD BIOTOOLS INC..
  - Action: resigned
  - Role: Director
  source text: Stephen Christopher Linthwaite, Ana K. Stankovic and Nicolas M. Barthelemy each resigned from the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/0001193125-22-096290-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.